Kazazian Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Kazazian Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$217K	Hold	2,177	–	–	0.29%	44
2019 Q2	$238K	Sell	2,177 -1,088	-33%	-$116K	0.28%	51
2019 Q1	$365K	Sell	3,265 -457	-12%	-$50.1K	0.51%	37
2018 Q4	$359K	Sell	3,722 -3,778	-50%	-$401K	0.49%	38
2018 Q3	$915K	Hold	7,500	–	–	0.86%	31
2018 Q2	$824K	Hold	7,500	–	–	0.76%	30
2018 Q1	$801K	Buy	+7,500	New	+$831K	0.84%	31
2015 Q4	–	Sell	-7,800	Closed	-$789K	–	72
2015 Q3	$789K	Buy	+7,800	New	+$936K	1%	24

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Kazazian Asset Management's IBB Position: Q3 2019 in Review

Kazazian Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2019 at 2,177 shares worth $217K. The position accounts for 0.29% of the portfolio, ranked #44.

Kazazian Asset Management first reported a position in IBB in Q3 2015 and has held it in 8 quarters since. The position peaked at $915K in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Kazazian Asset Management held 2,177 shares of iShares Biotechnology ETF worth $217K as of Q3 2019.
Kazazian Asset Management left its iShares Biotechnology ETF share count unchanged in Q3 2019.
iShares Biotechnology ETF made up 0.29% of Kazazian Asset Management's portfolio in Q3 2019, its #44 holding.
Kazazian Asset Management first reported a position in iShares Biotechnology ETF in Q3 2015 and has held it in 8 quarters since.
Kazazian Asset Management's iShares Biotechnology ETF position peaked at $915K in Q3 2018.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.